Cover Story


    The pharma industry, one of the key stakeholders of public health, have a huge responsibility to ‘do good’ and ‘be part of the solution’


    Rapid adoption of disruptive technologies are bringing in new approaches and outcomes in the pharma sector. An analysis By Lakshmipriya Nair

  • Continually evolving solid dosage forms

    Solid dosage forms are a preferred option of drug administration. But, deployment of novel materials and new age manufacturing processes, supported by technology, to meet the evolving requirements of...

  • Sikkim’s tryst with pharma sector

    Pharma companies are making a beeline to the tiny Himalayan state of Sikkim lured by good government policies, conducive business environment, low cost manufacturing and easy availability of labour

  • Flying it for pharma

    The air cargo industry needs to up its game by ensuring reliability and safety across the supply chain to leverage the growth potential in pharma logistics

  • Making it future ready

    On Teachers’ Day, experts comment on ways to improve pharmacy education in the country

  • Build excitement in the learning process | Dr B Suresh

    From time immemorial medicinal plants have been the source of many new drugs and the discovery of new molecules. With the systematic organisation of these plants and their uses,...

  • Need to re-engineer pharmacognosy science | Dr Swarnlata Saraf

    The pharmacognosy branch of pharmaceutical sciences can  remain in the pharmacy profession with re-engineering the contents according to the views of a pharmacist and not on the basis of...

  • The subject is essential for pharma science | Dr N Udupa

    Pharmacognosy subject  is an essential area for the development of pharmaceutical sciences. Along with pharmacology, pharmaceutical chemistry and pharmaceutical technology, pharmacognosy is the foundation for the progress and development...

  • Pharmacognosy as a branch needs to be looked upon as a vast area | Dr Madhu Chitkara

    The first commercial pure natural product introduced for therapeutic use as pure compound was morphine from opium poppy plant marketed by Merck in 1826, and is till date the...

  • We need to upgrade ourselves | Prof Raghuram Rao Akkinepally

    How is NIPER, as a premier pharma education institute in India, encouraging adoption of industry best practices, providing intensive hands-on training, enabling compliance regulatory guidelines and ensuring high quality...

  • Institutes need to create an ecosystem | Prof Navin Sheth

    India Pharma Inc is on the brink of a huge transformation. What is the strategy shift that is needed in pharmacy education to accelerate the industry’s growth story? India...

  • We should aim for more research output | Dr N Udupa

     What is the strategy shift that is needed in pharmacy education to accelerate the industry’s growth story? The Indian pharma industry is globally well advanced and the country’s pharma...

  • There is a need to revamp education system | Prof Chandrakant Kokate

    How should we revamp our pharma education to provide more emphasis on clinical and practical training, with a research oriented way of learning? Pharmacy education is like a free-flowing...

  • Healing beyond boundaries, against all odds

    In Part Two of our Independence Day coverage, we identify trade and non-trade barriers faced by India Pharma Inc as it seeks to serve patients beyond boundaries by delivering...

  • In the quest of true freedom

    India Pharma Inc has come a long way since independence, but three ‘Is' namely, Indigenisation, Innovation and Information would play key roles in liberating its true potential

  • Revisiting Ayush Policy

    The government is trying to revive the AYUSH sector, but the success of its measures would rest on its ability to establish AYUSH as an evidence-based sector

  • Celebrating FR&D Leadership

    Following the successful first edition of Formulation and Drug Delivery (FDD) Conclave, The Indian Express (P) Ltd and Express Pharma recently hosted its second edition with the theme ‘Expanding...

  • Inaugural Ceremony

    After the lamp lighting ceremony, the dignitaries also released the FDD Leaders Handbook

  • KEYNOTE ADDRESS: Embracing complexity through drug delivery systems and innovation

    Delivering a key note address at FDD Conclave on ‘Embracing complexity through drug delivery systems & innovation’, Dr Praveen Khullar, Head of Global Development Centre, Group Sanofi, Goa started...

  • Quality by Design: Step-by-step Implementation for Formulation Development

    Ranjit Barshikar, QbD/ cGMP Consultant & Member of Editorial Board, Journal of Generic Medicines, England gave a comprehensive presentation on the steps to implement Quality by Design in formulations

  • Capsule-based Inhalation Drug Delivery: Expanding Horizons

    The speaker briefed the audience on inhalation drug delivery and capsule based dry powder inhalation (cPDI)

  • AccelTRA – Primary Packaging Solutions for Generic Injectables

    Alok Chandorkar, Market Development Manager-India, West Pharmaceutical Packaging India gave a presentation on 'Your Partner for Integrated Containment and Delivery Solutions' at FDD Conclave 2018

  • Product launch by Ideal Cures: INSTACOAT QD and INSTACOAT T2F

    Audience at FDD Conclave 2018 interacting and checking out the products lauched by Ideal Cures

  • PANEL DISCUSSION: Regulatory Pathways for Specialty/ Complex Generics

    The first panel discussion at FDD Conclave 2018 was on Regulatory Pathways for Specialty/ Complex Generics

  • Vaccine Delivery – An Emerging Opportunity

    Day 2 of FDD Conclave 2018, began with a very insightful session titled, ‘Vaccine Delivery - An Emerging Opportunity’

  • Ideal Cures Document Solutions

    Suresh Pareek, MD Ideal Cures, the presenting partner at FDD Conclave 2018, showcased an interesting offering, Ideal Cures Documented Solutions, before the leading professionals gathered at the event